These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 16170959)

  • 1. [Epidemiologic and situational panorama of hepatitis C in Mexico].
    Vera de León L; Juárez Navarro JA; Díaz Gómez M; Méndez Navarro J; Chirino Sprung RA; Dehesa Violante M; Casillas Davila L; Rizo Robles MT; Torres Ibarra R; Cano Domínguez C; Nava Estrada J; Ramos Gómez M; Hernández ME; Wong González S; Félix Tamayo M; Corona Lechuga Mdel C; Zárate Negrete AR; Rangel Jiménez M; Rodríguez Hernández H; González Ortiz V; Tirado Estrella MP; Villanueva Carreto ML; Orta Flores R; Manteca Argumedo JL; Vázquez Avila I; González Macias J; Razcón Hernández O; Torres López P; Bazán Pérez C
    Rev Gastroenterol Mex; 2005; 70(1):25-32. PubMed ID: 16170959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of chronic hepatitis C virus genotypes among patients between 21 to 65 years old in Puerto Rico.
    Rodríguez-Pérez F; Suárez-Pérez E; Alvarez-Rohena M; Toro DH
    P R Health Sci J; 2004 Jun; 23(2 Suppl):49-56. PubMed ID: 16929587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in hepatitis C virus infection routes and genotype distribution in a Lithuanian cohort with chronic hepatitis C.
    Liakina V; Speiciene D; Irnius A; Valantinas J
    Med Sci Monit; 2009 Apr; 15(4):PH17-23. PubMed ID: 19333213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sexual activity as a risk factor for hepatitis C in Puerto Rico.
    De Jesús-Caraballo J; Toro DH; Rodríguez-Pérez F; Ruiz H; Dueño MI; Alvarez M; Suárez-Pérez E;
    Bol Asoc Med P R; 2008; 100(3):15-20. PubMed ID: 19227710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
    Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
    Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidemiology of chronic hepatitis C in Germany--an analysis of 10,326 patients in hepatitis centres and outpatient units].
    Hüppe D; Zehnter E; Mauss S; Böker K; Lutz T; Racky S; Schmidt W; Ullrich J; Sbrijer I; Heyne R; Schober A; John C; Hey KH; Bokemeyer B; Kallinowski B; Möller B; Pape S; Gutmann M; Alshuth U; Niederau C
    Z Gastroenterol; 2008 Jan; 46(1):34-44. PubMed ID: 18188814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
    Wu CH; Xu XY; Tian GS; Yu YY
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus genotypes in 1,504 patients in Slovenia, 1993-2007.
    Seme K; Vrhovac M; Mocilnik T; Maticic M; Lesnicar G; Baklan Z; Volkar JM; Rajter M; Stepec S; Lunar M; Poljak M
    J Med Virol; 2009 Apr; 81(4):634-9. PubMed ID: 19235845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infection.
    Simó R; Lecube A; Genescà J; Esteban JI; Hernández C
    Diabetes Care; 2006 Nov; 29(11):2462-6. PubMed ID: 17065685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence of VHB and VHC serological markers among blood donors in the capital state of Veracruz, Mexico].
    Valerio-Ureña J; Vásquez-Fernández F; Pérez-Sosa JA; Cortazar-Benitez LF; Chávez-Tapia NC; Ruvalcaba-Rojas OA; Torres-Medina V; Ocejo-Rodríguez A
    Gac Med Mex; 2009; 145(3):183-7. PubMed ID: 19685823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding hepatitis C.
    Yim CK
    CANNT J; 2001; 11(3):24-30, 33-40; quiz 31-2, 41-2. PubMed ID: 11785189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C infection in Western Turkey.
    Altuglu I; Soyler I; Ozacar T; Erensoy S
    Int J Infect Dis; 2008 May; 12(3):239-44. PubMed ID: 17942359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C in 6,865 patients 65 yr or older: a severe and neglected curable disease?
    Thabut D; Le Calvez S; Thibault V; Massard J; Munteanu M; Di Martino V; Ratziu V; Poynard T
    Am J Gastroenterol; 2006 Jun; 101(6):1260-7. PubMed ID: 16771947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan.
    Yu ML; Lin SM; Chuang WL; Dai CY; Wang JH; Lu SN; Sheen IS; Chang WY; Lee CM; Liaw YF
    Antivir Ther; 2006; 11(8):985-94. PubMed ID: 17302368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in socio-economics, quality of life and knowledge of patients with chronic hepatitis C during the Hepatitis Competence Net Project].
    Niederau C; Bemba G; Kautz A
    Z Gastroenterol; 2008 Jan; 46(1):22-33. PubMed ID: 18188813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic hepatitis C in children: a clinical and immunohistochemical comparative study with adult patients.
    García-Monzón C; Jara P; Fernández-Bermejo M; Hierro L; Frauca E; Camarena C; Díaz C; De la Vega A; Larrauri J; García-Iglesias C; Borque MJ; Sanz P; García-Buey L; Moreno-Monteagudo JA; Moreno-Otero R
    Hepatology; 1998 Dec; 28(6):1696-701. PubMed ID: 9828237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiologic aspects of bronchial asthma in the Mexican Republic].
    Martínez-Cairo Cueto S; Salas-Ramírez M; Segura-Méndez NH
    Gac Med Mex; 1995; 131(3):277-82. PubMed ID: 8582565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Spectrum, incidence and prognostic value of systemic manifestations in chronic hepatitis C of low activity].
    Karpov SIu; Krel' PE; Lopatkina Tn; Krasnova TN; Milovanova SIu; Nekrasova TN
    Ter Arkh; 2005; 77(2):59-65. PubMed ID: 15807455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Incidence and risk factors for hepatitis A in the province of Guadalajara (Spain)].
    González Praetorius A; Rodríguez-Avial C; Fernández C; Pérez Pomata MT; Gimeno C; Bisquert J
    Gastroenterol Hepatol; 2002 Apr; 25(4):230-4. PubMed ID: 11975869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.